Benitec Biopharma Announces Updated Investor Webcast Information
-Management plans to host an investor webcast on October 14th at 8:30 am EDT to provide an update for the BB-301 Phase 1b/2a Clinical Study, details below- -The webcast access information has been revised from the conference call information provided on October 12th– HAYWARD, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) — Benitec Biopharma Inc. (NASDAQ: […]